Welcome
Support Centre
23 May 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
The effectiveness of a new computerised treatment, "Stressbusters", for young people (aged 11 to 16 years) with symptoms of depression
ISRCTN ISRCTN83507297
ClinicalTrials.gov identifier
Public title The effectiveness of a new computerised treatment, "Stressbusters", for young people (aged 11 to 16 years) with symptoms of depression
Scientific title Randomised controlled trial (RCT) comparing a computerised Cognitive Behavioural Therapy (CBT) program, called “Stressbusters”, to a wait-list control condition, in young people aged 11-16 years
Acronym N/A
Serial number at source N/A
Study hypothesis To evaluate the effectiveness of a recently developed computerised Cognitive Behavioural Therapy (C-CBT) program (called “Stressbusters”) for the school- based treatment of depressive symptoms in young people.

Principal research question:
For young people aged 11-16 years who have mild-moderate symptoms of depression (as identified in Part 1 of the project), is weekly use of the Stressbusters C-CBT program in school for 8-weeks associated with significant reductions in symptoms of depression, relative to a waiting list control condition (Part 2)?

Primary hypothesis:
At post treatment follow-up, young people who were randomly allocated to the Stressbusters group will have significantly fewer symptoms of depression, ascertained by scores on a standardised self report measure of depressive symptoms (the Mood and Feelings Questionnaire, MFQ, see below), compared to young people who were randomly allocated to the Wait List group, after controlling for initial symptom severity. This will be tested using Analysis of Covariance (ANCOVA).

Secondary hypotheses:
1. At post treatment follow-up, young people who were randomly allocated to the Stressbusters group will have significantly fewer symptoms of anxiety, ascertained by scores on a standardised self report measure of anxiety symptoms (Screen for Anxiety and Related Disorders, SCARED, see below), compared to young people who were randomly allocated to the Wait List group, after controlling for initial symptom severity. This will be tested using Analysis of Covariance (ANCOVA)
2. At post treatment follow-up, young people who were randomly allocated to the Stressbusters group will have significantly fewer symptoms of depression, anxiety, and emotional and behavioural problems as reported by parents and teachers using standardised report measures (MFQ-Parent report, SCARED-Parent report, Strengths and Difficulties Questionnaire for parents and teachers, see below), compared to young people who were randomly allocated to the Wait List group, after controlling for initial symptom severity. This will be tested using Multivariate Analysis of Covariance (MANCOVA)
3. Effects of treatment will be mediated by changes in young people’s thinking styles (measured using the Ruminative Response Styles Questionnaire, see below). This will be tested using a series of regression equations.
Lay summary Lay summary under review
Ethics approval Nursing & Midwifery Research Ethics Committee, King’s College London, 27 July 2010, ref: PNM/09/10-123
Study design Interventional randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Depression
Participants - inclusion criteria Part 1 (screening stage):
All consenting young people (male and female), in Years 7 to 12 (aged 11-16 years) attending mainstream secondary school.

Part 2 (Stressbusters RCT):
1. Young people (male and female), aged 11-16 years old currently experiencing significant symptoms of depression, as identified in Part 1.
2. A score of 20 or greater on a brief standardised self report measure of depression for young people, the Mood & Feelings Questionnaire (MFQ, Angold, Costello, et al 1987). This well-established threshold has 70% sensitivity and 81% specificity for detecting any mood disorder, including Major Depression and Dysthymia (Daviss et al 2006).


Participants - exclusion criteria Part 1 (screening stage):
Young people who are unable to read English.

Part 2 (Stressbusters RCT):
1. Young people who are receiving treatment for a mood disorder from their GP or local CAMHS clinic
2. Those reporting significant current risk of suicide
Anticipated start date 11/03/2011
Anticipated end date 30/09/2013
Status of trial Ongoing
Patient information material Not available in web format, please use the contact details below to request a patient information sheet
Target number of participants Part 1: 900 participants to be screened (part 1) over both sites. Part 2: 146 to be recruited into RCT (part 2) in total (73 in each group)
Interventions Randomised controlled trial comparing Stressbusters to wait-list control, conducted out of two secondary schools. Individual randomisation, stratified according to age, gender, and symptom severity.

Computerised CBT treatment called Stressbusters compared with “waitlist control” group. Stressbusters consists of eight weekly sessions delivered over nine to 11 weeks (one school term). Each session lasts 30 to 40 minutes. Follow up assessment to take place immediately post treatment and at three and six months post treatment.
Primary outcome measure(s) Severity of depression symptoms, as measured by the self-report Mood and Feelings Questionnaire (MFQ; Costello and Angold, 1988). The MFQ is to be administered pre- and post-intervention and again at three and six months follow up.
Secondary outcome measure(s) 1. Severity of self-reported anxiety symptoms, as measured by the Screen for Child Anxiety Related Disorders (SCARED; Birmaher et al., 2002). The SCARED is to be administered pre- and post-treatment and again at three and six months follow up.
2. Severity of depression, anxiety, and emotional and behavioural problems as reported by parents and teachers using standardised report measures (MFQ-Parent report; SCARED-Parent report, Strengths and Difficulties Questionnaire for teachers). These measures are to be administered pre- and post-treatment and again at three and six months follow up.
3. Changes in young peoples thinking styles, as measured by the Children’s Response Style Questionnaire (CRSQ; Abela, Brozina, & Haigh, 2002).
Sources of funding Guy's and St Thomas' Charity (UK)
Trial website
Publications
Contact name Dr  Patrick  Smith
  Address Institute of Psychiatry
Department of Psychology
King's College London
De Crespigny Park
  City/town London
  Zip/Postcode SE5 8AF
  Country United Kingdom
Sponsor King's College London (UK)
  Address c/o Mr Keith Brennan
Hodgkin Building
Guy's Campus
  City/town London
  Zip/Postcode SE1 1UL
  Country United Kingdom
  Tel +44 (0)20 7848 6960
  Fax +44 (0)20 7848 6394
  Email keith.brennan@kcl.ac.uk
  Sponsor website: http://www.kcl.ac.uk/index.aspx
Date applied 07/10/2011
Last edited 21/12/2011
Date ISRCTN assigned 21/12/2011
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central